CSI Market
Sign In | Register

Harmony Biosciences Holdings inc (HRMY) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access HRMY quarterly Cash Flow →
By examining cash flow figures across successive periods, users can identify shifts in Harmony Biosciences Holdings inc's cash generation and deployment strategy.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income158.69
Depreciation & amortization0.00
Amortization of Other Assets23.85
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories1.84
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation44.90
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Research And Development Asset Acquired Other Than Through Business Combination Written Off-
Stock Appreciation Rights Market Adjustment0.07
In Process Research And Development Acquired1.49
Income taxes-7.30
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-13.75
Increase (Decrease) in Accounts Payable, Trade3.95
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets31.79
Other Working Capital67.99
Other Noncash Expense1.33
Other net0.00
Payments for (Proceeds from) Other Operating Activities33.38
Discontinued operations0.00
Net Cash flow from Operating Activities348.20
Investing Activities
Capital Expenditures-0.31
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Available-for-sale Securities81.06
Payments to Acquire Available-for-sale Securities, Debt-86.15
Real Estate Investments0.00
Payments To Acquire In Process Research And Development Other Than Through Business Combination-
Cash Paid For Milestones-19.25
Payment Of License Fee Investing Activities-
Payment Of License Fee And Milestone Investing Activities-
Payment Of Upfront Fee Investing Activities-15.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-39.65
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-16.25
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock10.21
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-3.00
Payment Of Preferred Stock Issuance Costs-
Payments Of Extinguishment Of Debt Exit Fees-
Payment Of Initial Public Offering Issuance Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-9.05
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow347.89
Total Cash Flow299.50
4 historic quarters locked

Sign in to unlock the full Harmony Biosciences Holdings inc cash flow history.

Sign In Create Free Account

About Harmony Biosciences Holdings Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001104659-26-018859

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License